OVID Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:56):
Our systems believe the stock currently is undervalued by 0.10% compare to its pairs and should correct upwards.

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States...

Stats
Dagens volum	2.47M
Gjennomsnittsvolum	689 891
Markedsverdi	49.88M
EPS	$-0.170 ( Q1 \| 2024-05-14 )
Neste inntjeningsdato	( $-0.220 ) 2024-08-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.980 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00100 (0.14%)

AADI -5.59%

ABCL 1.28%

ABCM 0.04%

ABEO -3.09%

ABIO -0.30%

ABOS 0.47%

ABSI 4.42%

ABUS -1.31%

ABVX -3.00%

ACAD -0.61%

ACER -17.95%

ACET -9.18%

ACGN 1.29%

ACHL -1.70%

ACHV 3.02%

ACIU -0.62%

ACLX -0.31%

ACRV -4.13%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -3.70%

ADGI 0.87%

ADIL -2.63%

ADMA -1.50%

ADPT 0.44%

ADTX -3.47%

ADVM 0.94%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -3.15%

AGEN -4.44%

AGIO -2.93%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.18%

AKRO -2.23%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -1.95%

ALEC -0.80%

ALGS -1.08%

ALKS 1.65%

ALLK -11.44%

ALLO -2.71%

ALLR -3.67%

ALNA 3.16%

ALNY 2.15%

ALPN 0.02%

ALPX 0.00%

ALRN -2.17%

ALT -15.25%

ALVR -0.57%

ALXN 0.00%

ALXO -10.58%

ALZN 5.10%

AMRN -3.66%

AMTI -3.13%

ANAB 1.47%

ANEB 9.47%

ANGN 0.00%

ANIX -3.24%

ANL -0.14%

ANNX 2.07%

ANPC -3.15%

APGE 2.06%

APGN 8.48%

APGNW 30.65%

APLM -3.68%

APLS 0.35%

APLT -0.56%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 3.21%

ARAV -13.39%

ARCT -6.74%

ARDS -12.13%

ARDX 1.58%

ARGX -1.23%

ARNA 0.00%

ARPO -0.90%

ARQT -3.49%

ARTL -2.50%

ARTLW 0.00%

ARVN 6.36%

ARWR -2.34%

ASLN -2.45%

ASMB -7.14%

ASND -2.64%

ATAI -3.33%

ATHA 8.68%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 3.40%

ATRA -5.91%

ATXI 1.09%

ATXS -0.44%

AUPH -1.08%

AURA 4.70%

AUTL -3.30%

AVBP -3.26%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -0.69%

AVTX -4.26%

AVXL -5.68%

AXLA 0.00%

AXSM -2.12%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.88%

BCAB -7.84%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.81%

BCTX 12.35%

BCTXW 5.02%

BCYC 0.90%

BDRX -4.20%

BDTX -0.32%

BEAM 2.43%

BFRA -2.91%

BGNE -2.85%

BIOR -3.94%

BIVI 1.72%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -1.44%

BLU 0.03%

BLUE -4.41%

BMEA -14.97%

BMRN 0.38%

BNOX 4.46%

BNTC -5.48%

BNTX -2.13%

BOLD -10.84%

BOLT 0.32%

BPMC -2.30%

BPTH -5.24%

BPTS -13.47%

BRNS -0.37%

BRTX -6.23%

BTAI 14.47%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.75%

CABA 0.76%

CADL 1.33%

CALA 0.00%

CALC -0.04%

CALT -1.59%

CAPR 0.00%

CARA -12.11%

CARM 6.52%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 1.00%

CCCC -2.02%

CCXI 0.00%

CDAK 0.00%

CDIO -4.66%

CDIOW 24.00%

CDMO -1.13%

CDMOP 0.04%

CDT -3.57%

CDTTW -39.60%

CDTX -6.19%

CDXC 9.02%

CDXS 9.83%

CELC -3.03%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.63%

CERO -5.03%

CEROW -10.18%

CFRX -27.95%

CGEM 0.15%

CGEN -3.58%

CGON -2.90%

CGTX -3.95%

CHMA -6.00%

CHRS 4.75%

CINC 0.00%

CING -3.91%

CINGW 34.95%

CKPT -1.67%

CLBS -16.75%

CLDX -0.48%

CLGN -0.50%

CLLS -4.15%

CLNN -2.50%

CLNNW 0.00%

CLRB 7.41%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 3.23%

CMPI 0.00%

CMPX 1.89%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -33.10%

CNST 0.00%

CNTA 0.84%

CNTB -1.50%

CNTX -9.29%

COCP -1.84%

COEPW 32.45%

COGT -2.64%

CORT 3.85%

COYA -2.44%

CPRX -0.63%

CRBP -1.67%

CRBU -7.67%

CRDF 2.93%

CRGX -1.41%

CRIS -2.64%

CRNX -5.92%

CRSP 1.30%

CRTX 2.63%

CRVO -8.15%

CRVS 0.70%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -2.06%

CTNM 6.67%

CTXR -5.96%

CUE -2.77%

CVAC -5.08%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 20.75%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.28%

CYTO 0.00%

DARE 0.86%

DAWN 0.15%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 31.42%

DNLI -1.74%

DNTH -2.11%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.42%

DTIL 1.56%

DYAI 8.39%

EARS -1.77%

EDIT -3.22%

EDSA 4.14%

EFTR -0.75%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.14%

ELEV -1.87%

ELOX 10.77%

ELTX -3.38%

ELVN -0.65%

ELYM 7.95%

ENGN -0.25%

ENGNW -21.67%

ENLV 0.72%

ENOB 1.79%

ENSC 6.55%

ENTA -0.41%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -1.03%

EPRX -2.87%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 7.23%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -6.36%

ETON 2.44%

ETTX 0.00%

EVAX -0.18%

EVGN 4.11%

EVLO 0.00%

EWTX 0.74%

EXAI -0.28%

EXEL 0.61%

EYEG -0.69%

EYEN 0.02%

EYPT -0.85%

FATE -12.22%

FBIO 0.89%

FBIOP 0.87%

FBLG -11.04%

FBRX -0.04%

FDMT -4.52%

FENC -3.07%

FGEN -10.26%

FHTX 6.97%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.87%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.89%

FULC 3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -1.54%

GBIO -0.71%

GBT 0.01%

GDTC 2.03%

GERN -1.66%

GHRS -4.27%

GLMD -2.48%

GLPG -1.87%

GLSI 10.53%

GLTO -3.90%

GLUE -2.37%

GLYC -12.96%

GMAB -0.45%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.65%

GNPX -4.41%

GNTA 3.94%

GOSS -7.75%

GOVX -7.27%

GOVXW 10.89%

GPCR -5.56%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.27%

GRTX -1.66%

GTHX 2.05%

GUTS 1.11%

GXGXW 41.67%

GYRE -6.51%

HALO -0.73%

HARP 0.09%

HCWB -6.93%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX 0.69%

HOOK 1.02%

HOTH -3.78%

HOWL 0.21%

HRMY 3.52%

HRTX 8.36%

HSTO 0.00%

HUMA 1.62%

HUMAW -6.25%

IBRX -6.81%

ICCC -2.10%

ICPT 0.21%

ICU 19.78%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.27%

IFRX -3.40%

IGMS -3.07%

IKNA -3.87%

IKT -2.08%

IMAB 0.00%

IMCR -3.90%

IMGN 0.02%

IMGO 0.00%

IMMP 5.51%

IMMX -3.03%

IMNM 3.81%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.42%

IMTXW 6.00%

IMUX -6.48%

IMV 0.00%

IMVT -4.29%

INAB -1.12%

INBX -3.11%

INCY -2.10%

INDP 6.88%

INFI -52.38%

INKT 0.00%

INM 3.06%

INMB 0.14%

INO 1.83%

INSM -0.96%

INTS -3.73%

INVA 0.84%

INZY 1.26%

IOBT -7.48%

IONS 1.28%

IOVA -3.91%

IPA 1.07%

IPHA 2.54%

IPSC -2.73%

IRON -1.24%

ISEE 0.38%

ITOS 2.67%

ITRM 1.36%

IVA 6.96%

IVVD 0.00%

JAGX 0.52%

JANX -4.41%

JAZZ -0.77%

JNCE 0.00%

JSPR -2.14%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.49%

KALV -2.51%

KDNY 0.22%

KMPH -0.34%

KNSA -2.37%

KNTE -0.38%

KOD -9.31%

KPRX -5.76%

KPTI -8.55%

KRBP -10.00%

KRON 1.64%

KROS -0.26%

KRRO -0.51%

KRTX 0.03%

KRYS 0.92%

KTRA 9.38%

KTTA -0.65%

KTTAW 0.92%

KURA 0.63%

KYMR -3.76%

KYTX -5.81%

KZIA 6.21%

KZR -1.86%

LABP 0.57%

LBPH 1.23%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.06%

LENZ -3.59%

LEXX 0.58%

LEXXW -14.63%

LGND -1.11%

LGNDV 0.00%

LGVN -9.57%

LIAN -8.28%

LIFE 2.70%

LIPO -9.42%

LIXT -9.85%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.43%

LPCN -4.36%

LPTX -0.55%

LQDA 0.33%

LRMR -0.21%

LSTA -1.68%

LTRN 6.55%

LUMO 0.67%

LVTX -3.12%

LXEO -12.83%

LXRX -0.59%

LYEL -36.12%

LYRA 4.22%

MACK 0.10%

MBIO -11.51%

MBRX -1.43%

MCRB 0.60%

MDGL -2.13%

MDNA -13.16%

MDWD 3.84%

MDXG -1.62%

MEIP 0.70%

MESO -1.63%

MGNX -5.48%

MGTA -7.74%

MGTX 0.95%

MGX 3.08%

MIRM -0.44%

MIRO 0.59%

MIST 1.92%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 1.16%

MLYS -8.96%

MNKD -0.76%

MNMD 3.68%

MNOV 1.41%

MNPR -9.34%

MOLN 0.76%

MOR 0.62%

MORF -3.04%

MREO 0.00%

MRKR -0.43%

MRNA -10.96%

MRNS -6.62%

MRSN -3.33%

MRTX -0.17%

MRUS 0.56%

MRVI 1.60%

MTCR -1.29%

MTEM 7.43%

MTP -18.50%

MURA -4.95%

MYMD 2.16%

NAMS 0.46%

NAMSW 0.64%

NAUT -1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -0.32%

NEXI 1.50%

NGM -1.28%

NGNE 2.89%

NKGN 11.51%

NKGNW -20.00%

NKTR 0.93%

NKTX -2.94%

NLSP 5.57%

NLSPW 26.67%

NMRA -1.26%

NMTR -42.97%

NOVN -24.84%

NRBO 12.45%

NRIX -1.51%

NRSN 0.78%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.58%

NTRBW -31.07%

NUVL -1.98%

NVAX -6.11%

NVCT -7.89%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 2.90%

OABIW -10.06%

OBIO 0.29%

OBSV 0.00%

OCEA -3.52%

OCGN 7.23%

OCS -1.00%

OCUL 0.69%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.99%

OMER -2.57%

OMGA -4.17%

ONCO 6.17%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.48%

ONTX -0.47%

ONVO 1.01%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -3.12%

ORMP 15.18%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.56%

OVID 0.44%

OYST 0.00%

PALI -0.48%

PASG -0.22%

PBLA -7.50%

PBM -3.43%

PBYI 5.07%

PCSA 0.00%

PCVX 0.54%

PDSB -4.48%

PEPG 1.37%

PGEN -6.59%

PHAR 1.99%

PHAS 0.00%

PHAT -0.48%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.75%

PLUR 10.34%

PMN -5.55%

PMVP -1.19%

PNT 0.16%

PPBT 1.64%

PRAX 5.53%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 2.02%

PRQR 1.20%

PRTA -3.71%

PRTC 6.52%

PRTG 0.09%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -13.94%

PSTX -4.08%

PTCT -0.46%

PTE -0.82%

PTGX 0.25%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.08%

QLGN -5.83%

QNCX 2.23%

QNRX 0.84%

QSI -28.46%

QSIAW -9.44%

QTTB 4.20%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -1.46%

RARE 1.93%

RCKT -10.50%

REGN -0.17%

RENB -3.11%

REPL -1.76%

RETA 0.02%

REUN -0.89%

REVB -3.21%

REVBU 3.46%

REVBW 4.35%

RGLS -4.67%

RGNX -6.66%

RIGL -6.25%

RLAY -6.61%

RLMD 0.00%

RLYB -5.70%

RNA 2.52%

RNAC 2.12%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.22%

ROIVW 4.56%

RPHM -1.56%

RPRX -1.10%

RPTX -1.75%

RUBY 2.70%

RVLP -32.05%

RVMD -1.13%

RVMDW -29.90%

RVNC -0.43%

RVPH -0.71%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.40%

RYTM -6.36%

RYZB 0.02%

RZLT 3.12%

SABS -1.37%

SABSW -5.53%

SAGE -0.55%

SANA -2.77%

SAVA -3.68%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 3.30%

SCPH 11.49%

SCPS 0.00%

SEEL -3.16%

SEER -1.18%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.11%

SGMT -4.59%

SGTX -2.56%

SIOX 22.63%

SLDB -2.24%

SLGL 5.23%

SLN -8.32%

SLNO 1.69%

SLRX 0.40%

SLS -3.85%

SMMT -2.93%

SNDX 1.94%

SNGX 4.45%

SNPX -2.77%

SONN -1.59%

SPPI -0.49%

SPRB -1.79%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -0.67%

SRRA 0.00%

SRRK -2.42%

SRZN -2.45%

STAB 0.00%

STOK -7.10%

STRO -2.00%

STSA 0.00%

STTK 7.03%

SURF -0.93%

SVRA -1.71%

SWTX -0.52%

SYBX 0.00%

SYRS -1.90%

TALS -0.73%

TARA -7.14%

TARS -2.09%

TBPH 0.24%

TCBP 9.98%

TCDA 0.00%

TCON -0.71%

TCRR 0.00%

TCRT -1.65%

TCRX -1.13%

TECH -1.40%

TENX -0.89%

TERN -6.69%

TFFP -11.51%

TGTX -7.71%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.65%

TNGX -4.10%

TNXP -10.40%

TNYA -5.78%

TPST 3.88%

TRDA -4.74%

TRVI 1.92%

TRVN 2.28%

TSHA -16.61%

TSVT -4.39%

TTNP -6.21%

TVTX 4.34%

TYRA -6.95%

UBX -2.73%

UNCY -4.00%

URGN 4.52%

UTHR -0.07%

VACC 11.36%

VALN -3.15%

VAXX 118.75%

VBIV -0.79%

VBLT -8.77%

VCEL 1.80%

VCNX 5.44%

VCYT -0.97%

VERA -4.46%

VERU 1.40%

VERV -3.82%

VIGL 1.08%

VINC 2.81%

VIR -1.30%

VIRI -5.42%

VIRX 0.31%

VKTX -0.88%

VLON -13.04%

VNDA -2.52%

VOR -6.45%

VRCA 0.14%

VRDN -2.90%

VRNA -1.99%

VRPX 3.58%

VRTX 0.07%

VSTM 4.59%

VTGN -2.41%

VTVT 1.28%

VTYX -2.72%

VXRT -1.73%

VYGR -0.51%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -7.86%

XBIO 1.03%

XBIT 4.58%

XCUR 0.23%

XENE -1.07%

XERS 5.24%

XFOR 6.25%

XLO 3.29%

XLRN 0.00%

XNCR 0.31%

XOMA -6.93%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.71%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.70%

ZNTL -1.90%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-03-18	Levin Jeremy M	Buy	18 248	Common Stock
2024-02-22	Tardio Jason	Buy	168 750	Stock Option (Right to Buy)
2024-02-22	Tardio Jason	Buy	28 125	Common Stock
2024-02-22	Rona Jeffrey A	Buy	28 125	Common Stock
2024-02-22	Rona Jeffrey A	Buy	168 750	Stock Option (Right to Buy)

INSIDER POWER
28.14
Last 96 transactions
Buy: 16 581 029 \| Sell: 7 414 277

Korrelasjon (AI algo v.1.1b): Undervalued: 0.10% $0.704 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.05 (neutral)

Kort: -0.09 (neutral)

Signal:(67.194) Neutral

Ovid Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Ovid Therapeutics Inc Korrelasjon - Valuta/Råvare

0.00
( neutral )

-0.02
( neutral )

Ovid Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$391 695
Bruttogevinst:	$-1.20M (-307.61 %)
EPS:	$-0.740

FY	2023
Omsetning:	$391 695
Bruttogevinst:	$-1.20M (-307.61 %)
EPS:	$-0.740

FY	2022
Omsetning:	$1.50M
Bruttogevinst:	$121 142 (8.06 %)
EPS:	$-0.730

FY	2021
Omsetning:	$208 383
Bruttogevinst:	$208 383 (100.00 %)
EPS:	$0.00182

Financial Reports:

No articles found.

Ovid Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Ovid Therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.